健帆生物(300529.SZ)发布前三季度业绩，归母净利润4.53亿元，下降42.75%

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company's operating revenue for the first three quarters was 1.556 billion yuan, representing a year-on-year decrease of 29.13% [1] - The net profit attributable to shareholders of the listed company was 453 million yuan, down 42.75% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 438 million yuan, reflecting a year-on-year decrease of 41.87% [1] - The basic earnings per share were 0.59 yuan [1]